Viatris Drug Patent Portfolio
Viatris owns 14 orange book drugs protected by 51 US patents with Nitrostat having the least patent protection, holding only 1 patent. And Tobi Podhaler with maximum patent protection, holding 14 patents. Given below is the list of Viatris's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9265720 | Pharmaceutical formulations useful in the treatment of insomnia | 25 Feb, 2031 | Active |
| US10207066 | Aerosolization apparatus with capsule puncture alignment guide | 04 Nov, 2030 | Active |
| US8869794 | Aerosolization apparatus with capsule puncturing member | 12 Sep, 2028 | Active |
| US8071073 | Compositions comprising azelastine and methods of use thereof | 04 Jun, 2028 | Active |
| US9597281 | Pharmaceutical formulations useful in the treatment of insomnia | 06 Apr, 2027 | Active |
| US8518919 | Compositions comprising azelastine and methods of use thereof | 22 Nov, 2025 | Active |
| US9919050 | Compositions comprising azelastine | 22 Nov, 2025 | Active |
| US7559325 | Aerosolization apparatus with air inlet shield | 27 Oct, 2025 | Active |
| US7449012 | Automatic injector | 11 Sep, 2025 | Active |
| US7794432 | Automatic injector with kickback attenuation | 11 Sep, 2025 | Active |
| US8048035 | Automatic injector with needle cover | 11 Sep, 2025 | Active |
| US8870827 | Automatic injector | 11 Sep, 2025 | Active |
| US9586010 | Automatic injector with needle cover | 11 Sep, 2025 | Active |
| US8664187 | Methods of treatment of endobronchial infections | 20 Jun, 2025 | Expired |
| US11484671 | Aerosolization apparatus with capsule puncture alignment guide | 07 Nov, 2024 | Expired |
| US8069851 | Aeorosolization apparatus with air inlet shield | 24 Sep, 2024 | Expired |
| USRE47526 | Aerosolization apparatus with air inlet shield | 09 Apr, 2024 | Expired |
| US7516741 | Aerosolization apparatus with feedback mechanism | 11 Jan, 2024 | Expired |
| US7368102 | Pulmonary delivery of aminoglycosides | 19 Dec, 2022 | Expired |
| US8715623 | Pulmonary delivery of aminoglycoside | 19 Dec, 2022 | Expired |
| US9421166 | Pulmonary delivery of aminoglycoside | 19 Dec, 2022 | Expired |
| US7256216 | Liquid pharmaceutical compositions | 28 Nov, 2022 | Expired |
| US7198801 | Formulations for transdermal or transmucosal application | 25 Jun, 2022 | Expired |
| US7256216 | Liquid pharmaceutical compositions | 28 May, 2022 | Expired |
| US7470433 | Formulations for transdermal or transmucosal application | 03 Aug, 2021 | Expired |
| US7097827 | Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments | 27 Jun, 2021 | Expired |
| US7442388 | Phospholipid-based powders for drug delivery | 10 May, 2020 | Expired |
| US8349294 | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use | 10 May, 2020 | Expired |
| US6469012 | Pyrazolopyrimidinones for the treatment of impotence | 22 Apr, 2020 | Expired |
| US6727283 | Sertraline oral concentrate | 11 Apr, 2020 | Expired |
| US7067555 | Sertraline oral concentrate | 11 Apr, 2020 | Expired |
| US6469012 | Pyrazolopyrimidinones for the treatment of impotence | 22 Oct, 2019 | Expired |
| US6727283 | Sertraline oral concentrate | 11 Oct, 2019 | Expired |
| US7067555 | Sertraline oral concentrate | 11 Oct, 2019 | Expired |
| US6761910 | Pharmaceutical composition for the treatment of acute disorders | 24 Sep, 2019 | Expired |
| US8512747 | Pharmaceutical composition for the treatment of acute disorders | 24 Sep, 2019 | Expired |
| US6150366 | Ziprasidone formulations | 27 May, 2019 | Expired |
| US6245766 | Method of treating psychiatric conditions | 18 Dec, 2018 | Expired |
| US6500456 | Compressed nitroglycerin tablet and its method of manufacture | 16 Sep, 2018 | Expired |
| US6054482 | Lactam-free amino acids | 25 Oct, 2017 | Expired |
| US6054482 | Lactam-free amino acids | 25 Apr, 2017 | Expired |
| US6232304 | Inclusion complexes of aryl-heterocyclic salts | 01 Apr, 2017 | Expired |
| US6399777 | Inclusion complexes of aryl-heterocyclic salts | 01 Apr, 2017 | Expired |
| US6110918 | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist | 26 Mar, 2017 | Expired |
| US5886039 | Method and composition for treating erectile dysfunction | 23 Mar, 2016 | Expired |
| US5508269 | Aminoglycoside formulation for aerosolization | 19 Oct, 2014 | Expired |
| US5248699 | Sertraline polymorph | 13 Feb, 2013 | Expired |
| US5474535 | Dosage and inserter for treatment of erectile dysfunction | 12 Dec, 2012 | Expired |
| US5250534 | Pyrazolopyrimidinone antianginal agents | 27 Sep, 2012 | Expired |
| US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride | 01 Sep, 2012 | Expired |
| US5248699 | Sertraline polymorph | 13 Aug, 2012 | Expired |
Latest Legal Activities on Viatris's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Viatris.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Court Processing Terminated | 17 Apr, 2024 | US7516741 |
|
Maintenance Fee Reminder Mailed
Critical
| 15 Apr, 2024 | US9421166 |
| Court Processing Terminated | 01 Mar, 2024 | US7097827 |
| Court Processing Terminated | 28 Feb, 2024 | US7442388 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 May, 2023 | US8071073 (Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 Apr, 2023 | US8048035 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 Apr, 2023 | US8048035 |
|
Recordation of Patent Grant Mailed
Critical
| 01 Nov, 2022 | US11484671 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 01 Nov, 2022 | US11484671 |
|
Email Notification
Critical
| 13 Oct, 2022 | US11484671 |
|
Issue Notification Mailed
Critical
| 12 Oct, 2022 | US11484671 |
|
Application Is Considered Ready for Issue
Critical
| 26 Sep, 2022 | US11484671 |
| Dispatch to FDC | 26 Sep, 2022 | US11484671 |
|
Issue Fee Payment Verified
Critical
| 23 Sep, 2022 | US11484671 |
|
Issue Fee Payment Received
Critical
| 23 Sep, 2022 | US11484671 |
Viatris's Drug Patent Litigations
Viatris's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 23, 2000, against patent number US6469012. The petitioner , challenged the validity of this patent, with ELLIS et al as the respondent. Click below to track the latest information on how companies are challenging Viatris's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10207066 | October, 2016 |
Decision
(18 Sep, 2018)
| Michael John Dunkley et al | |
| US8071073 | May, 2014 |
Terminated-Denied
(29 Jul, 2014)
| Meda Pharmaceuticals Inc. | Impax Laboratories, Inc. |
| US10207066 | May, 2009 |
Decision
(23 Dec, 2011)
| Michael John Dunkley et al | |
| US6469012 | May, 2000 |
Decision
(29 Nov, 2000)
| ELLIS et al | |
Viatris Drug Patents' Oppositions Filed in EPO
Viatris drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Dec 12, 2012, by Norton Healthcare Limited. This opposition was filed on patent number EP04759324A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP10155967A | Jan, 2021 | Keilitz Haines & Partner Patentanwälte PartGmbB | Granted and Under Opposition |
| EP10155967A | Apr, 2020 | ALK-ABELLO A/S | Granted and Under Opposition |
| EP05783727A | Nov, 2016 | ALK-ABELLO A/S | Revoked |
| EP05783727A | Nov, 2016 | Merck Patent GmbH | Revoked |
| EP05783727A | Oct, 2016 | Meridian Medical Technologies, Inc. | Revoked |
| EP09173753A | Jul, 2016 | Merck Patent GmbH | Patent maintained as amended |
| EP10194414A | Feb, 2015 | Feldmeier, Jürgen | Revoked |
| EP10194414A | Nov, 2014 | ALK-ABELLO A/S | Revoked |
| EP04759324A | Dec, 2012 | NORTON HEALTHCARE LIMITED | Patent maintained as amended |
Viatris's Family Patents
Viatris Drug List
Given below is the complete list of Viatris's drugs and the patents protecting them.
1. Astepro
Astepro is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8071073 | Compositions comprising azelastine and methods of use thereof |
04 Jun, 2028
(2 years from now)
| Active |
| US8518919 | Compositions comprising azelastine and methods of use thereof |
22 Nov, 2025
(5 months from now)
| Active |
| US9919050 | Compositions comprising azelastine |
22 Nov, 2025
(5 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Astepro's drug page
2. Edluar
Edluar is protected by 4 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9265720 | Pharmaceutical formulations useful in the treatment of insomnia |
25 Feb, 2031
(5 years from now)
| Active |
| US9597281 | Pharmaceutical formulations useful in the treatment of insomnia |
06 Apr, 2027
(1 year, 9 months from now)
| Active |
| US6761910 | Pharmaceutical composition for the treatment of acute disorders |
24 Sep, 2019
(5 years ago)
| Expired |
| US8512747 | Pharmaceutical composition for the treatment of acute disorders |
24 Sep, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Edluar's drug page
3. Elestrin
Elestrin is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7198801 | Formulations for transdermal or transmucosal application |
25 Jun, 2022
(2 years ago)
| Expired |
| US7470433 | Formulations for transdermal or transmucosal application |
03 Aug, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Elestrin's drug page
4. Epipen
Epipen is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7449012 | Automatic injector |
11 Sep, 2025
(2 months from now)
| Active |
| US7794432 | Automatic injector with kickback attenuation |
11 Sep, 2025
(2 months from now)
| Active |
| US8048035 | Automatic injector with needle cover |
11 Sep, 2025
(2 months from now)
| Active |
| US8870827 | Automatic injector |
11 Sep, 2025
(2 months from now)
| Active |
| US9586010 | Automatic injector with needle cover |
11 Sep, 2025
(2 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Epipen's drug page
5. Epipen Jr.
Epipen Jr. is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7449012 | Automatic injector |
11 Sep, 2025
(2 months from now)
| Active |
| US7794432 | Automatic injector with kickback attenuation |
11 Sep, 2025
(2 months from now)
| Active |
| US8048035 | Automatic injector with needle cover |
11 Sep, 2025
(2 months from now)
| Active |
| US8870827 | Automatic injector |
11 Sep, 2025
(2 months from now)
| Active |
| US9586010 | Automatic injector with needle cover |
11 Sep, 2025
(2 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Epipen Jr.'s drug page
Explore Our Curated Drug Screens
6. Geodon
Geodon is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6150366 | Ziprasidone formulations |
27 May, 2019
(6 years ago)
| Expired |
| US6245766 | Method of treating psychiatric conditions |
18 Dec, 2018
(6 years ago)
| Expired |
| US6232304 | Inclusion complexes of aryl-heterocyclic salts |
01 Apr, 2017
(8 years ago)
| Expired |
| US6399777 | Inclusion complexes of aryl-heterocyclic salts |
01 Apr, 2017
(8 years ago)
| Expired |
| US6110918 | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist |
26 Mar, 2017
(8 years ago)
| Expired |
| US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
01 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Geodon's drug page
7. Muse
Muse is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5886039 | Method and composition for treating erectile dysfunction |
23 Mar, 2016
(9 years ago)
| Expired |
| US5474535 | Dosage and inserter for treatment of erectile dysfunction |
12 Dec, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Muse's drug page
8. Neurontin
Neurontin is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7256216
(Pediatric)
| Liquid pharmaceutical compositions |
28 Nov, 2022
(2 years ago)
| Expired |
| US7256216 | Liquid pharmaceutical compositions |
28 May, 2022
(3 years ago)
| Expired |
| US6054482
(Pediatric)
| Lactam-free amino acids |
25 Oct, 2017
(7 years ago)
| Expired |
| US6054482 | Lactam-free amino acids |
25 Apr, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neurontin's drug page
9. Nitrostat
Nitrostat is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500456 | Compressed nitroglycerin tablet and its method of manufacture |
16 Sep, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nitrostat's drug page
10. Revatio
Revatio is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5250534
(Pediatric)
| Pyrazolopyrimidinone antianginal agents |
27 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Revatio's drug page
11. Tobi
Tobi is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5508269 | Aminoglycoside formulation for aerosolization |
19 Oct, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tobi's drug page
12. Tobi Podhaler
Tobi Podhaler is protected by 14 patents, out of which 11 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10207066 | Aerosolization apparatus with capsule puncture alignment guide |
04 Nov, 2030
(5 years from now)
| Active |
| US8869794 | Aerosolization apparatus with capsule puncturing member |
12 Sep, 2028
(3 years from now)
| Active |
| US7559325 | Aerosolization apparatus with air inlet shield |
27 Oct, 2025
(4 months from now)
| Active |
| US8664187 | Methods of treatment of endobronchial infections |
20 Jun, 2025
(a day ago)
| Expired |
| US11484671 | Aerosolization apparatus with capsule puncture alignment guide |
07 Nov, 2024
(7 months ago)
| Expired |
| US8069851 | Aeorosolization apparatus with air inlet shield |
24 Sep, 2024
(8 months ago)
| Expired |
| USRE47526 | Aerosolization apparatus with air inlet shield |
09 Apr, 2024
(1 year, 2 months ago)
| Expired |
| US7516741 | Aerosolization apparatus with feedback mechanism |
11 Jan, 2024
(1 year, 5 months ago)
| Expired |
| US7368102 | Pulmonary delivery of aminoglycosides |
19 Dec, 2022
(2 years ago)
| Expired |
| US8715623 | Pulmonary delivery of aminoglycoside |
19 Dec, 2022
(2 years ago)
| Expired |
| US9421166 | Pulmonary delivery of aminoglycoside |
19 Dec, 2022
(2 years ago)
| Expired |
| US7097827 | Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
27 Jun, 2021
(3 years ago)
| Expired |
| US7442388 | Phospholipid-based powders for drug delivery |
10 May, 2020
(5 years ago)
| Expired |
| US8349294 | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
10 May, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tobi Podhaler's drug page
13. Viagra
Viagra is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6469012
(Pediatric)
| Pyrazolopyrimidinones for the treatment of impotence |
22 Apr, 2020
(5 years ago)
| Expired |
| US6469012 | Pyrazolopyrimidinones for the treatment of impotence |
22 Oct, 2019
(5 years ago)
| Expired |
| US5250534
(Pediatric)
| Pyrazolopyrimidinone antianginal agents |
27 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Viagra's drug page
14. Zoloft
Zoloft is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6727283
(Pediatric)
| Sertraline oral concentrate |
11 Apr, 2020
(5 years ago)
| Expired |
| US7067555
(Pediatric)
| Sertraline oral concentrate |
11 Apr, 2020
(5 years ago)
| Expired |
| US6727283 | Sertraline oral concentrate |
11 Oct, 2019
(5 years ago)
| Expired |
| US7067555 | Sertraline oral concentrate |
11 Oct, 2019
(5 years ago)
| Expired |
| US5248699
(Pediatric)
| Sertraline polymorph |
13 Feb, 2013
(12 years ago)
| Expired |
| US5248699 | Sertraline polymorph |
13 Aug, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zoloft's drug page